MEDEXUS PHARMA, INC.
CHICAGO, IL

MEDEXUS PHARMA, INC., originally known as MEDAC PHARMA, INC., is a company dedicated to the advancement and commercialization of innovative therapies primarily targeting autoimmune diseases and cancer. With its headquarters in Leon County, DE, MEDEXUS PHARMA was incorporated on May 28, 2014, and holds a registered office at 29 N. Wacker Dr., Suite 704, Chicago, IL, with mailing addresses including a key presence through a Florida registration denoted by the filing number F14000002378. A pioneer in developing cutting-edge solutions, MEDEXUS PHARMA has introduced a novel methotrexate drug delivery system designed to enhance tolerability and bioavailability. This breakthrough empowers patients with greater control over their therapy management, improving both efficacy and quality of life for those suffering from severe health conditions. Interested parties are encouraged to explore their product portfolio online at medacpharma.com. The company's governance includes esteemed directors such as Ken D'Entremont, Brendon Buschman, and Michael Adelman who play pivotal roles in spearheading its strategic initiatives and ensuring adherence to its mission of leveraging evidence-based medicine for improved patient outcomes. The corporation is also noted for a formal name change event recorded on March 12, 2019. For inquiries or further information, they can be contacted via their multiple phone lines: (855) 336-3322; (312) 854-0500; and (312) 750-1082.